TO DEVELOP AN ORALLY AVAILABLE SMALL MOLECULE ANTIVIRAL DRUG, WITH TREATMENT OF YELLOW FEVER VIRUS INFECTION AS THE PRIMARY INDICATION.

Department of Health and Human Services